Beliefs about Depo-Provera among three groups of contraceptors.
This article examines the beliefs about Depo-Provera held by three groups of contraceptors utilizing urban family planning clinics in the United States (n = 836). Patients choosing Depo-Provera, oral contraceptives, and Norplant were asked about their beliefs regarding Depo-Provera in the following four domains: effectiveness in preventing pregnancy, convenience, side-effects, and risk to health; and also for their perceptions regarding the physical discomfort and cost associated with the method. Findings reveal that patients choosing the pill and Norplant give Depo-Provera significantly lower ratings for both convenience and effectiveness than do Depo-Provera acceptors. Given the documented effectiveness of Depo-Provera, this is a potential cause for concern. Moreover, Norplant and pill choosers are most likely to hold inaccurate beliefs regarding both the cost of Depo-Provera, and certain side-effects associated with its use. Although more than half of all patients believe the Depo-Provera would cause menstrual changes and weight gain, it is noteworthy that the proportions are not higher, given their known association with the method. Knowledge about the likelihood of these side-effects is essential, particularly for those choosing Depo-Provera. Implications for physicians, counselors, and other family planning professionals are discussed.
Cushman
L F
LF
Center for Population and Family Health, Columbia University School of Public Health, New York, NY 10032, USA.
Kalmuss
D
D
Davidson
A R
AR
Heartwell
S
S
Rulin
M
M
D000293:Adolescent; D000328:Adult; D003153:Community Health Services; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D005193:Family Planning Services; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000191:economics; D008599:Menstruation Disturbances / Q000139:chemically induced; D017060:Patient Satisfaction; D011247:Pregnancy; D012307:Risk Factors; D014505:Urban Population; D015430:Weight Gain
D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate